Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: The apoptotic effects of virus infection

Journal of Virology

Volumn 77, Issue 3, 2003, Pages 2134-2146

  Sung, M H Vicky ^a   Shimodaira, Shigetaka ^a   Doughty, Alison L ^a   Picchio, Gaston R ^d,e   Can, Huong ^a   Benedict Yen, T S ^b,c   Lindsay, Karen L ^a   Levine, Alexandra M ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e Ortho McNeil Pharmaceutical Incorporated   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 3; RIBONUCLEASE; RNA DIRECTED DNA POLYMERASE; SUCROSE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CELL CULTURE; CELL IMMORTALIZATION; CHRONIC HEPATITIS; EPSTEIN BARR VIRUS; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOMA CELL LINE; NONHODGKIN LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SPLEEN; VIRION; VIRUS INFECTION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; HEPACIVIRUS; HEPATOCYTES; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; RNA, VIRAL; TUMOR CELLS, CULTURED; VIRAL NONSTRUCTURAL PROTEINS; VIRION;

EID: 0037303112     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.3.2134-2146.2003     Document Type: Article

References (49)

1. Andre, P., F. Komurian-Pradel, S. Deforges, M. Perret, J. L. Berland, M. Sodoyer, S. Pol, C. Brechot, G. Paranhos-Baccala, and V. Lotteau. 2002. Characterization of low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol. 76:6919-6928.
2. Blight, K. J., A. A. Kolykhalov, and C. M. Rice. 2000. Efficient initiation of HCV RNA replication in cell culture. Science 290:1972-1974.
3. Bouvier-Alias, M., K. Patel, H. Dahari, S. Beaucourt, P. Larderie, L. Blatt, C. Hezode, G. Picchio, D. Dhumeaux, A. U. Neumann, J. G. McHutchison, and J.-M. Pawlotsky. 2002. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 36:211-218.
4. Cerny, A., and F. V. Chisari. 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30:595-601.
5. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
6. Doughty, A., P. M. Dorothy, and G. W. McCaughan. 2000. Post-transplant quasispecies pattern remains stable over time in patients with recurrent cholestatic hepatitis due to hepatitis C virus. J. Hepatol. 32:126-134.
7. Farrell, P. J. 1995. Epstein-Barr virus immortalizing genes. Trends Microbiol. 3:105-109.
8. Ferri, C., F. Caracciolo, and A. L. Zignego. 1994. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br. J. Haematol. 88:392-394.
9. Ghosh, A. K., R. Steele, K. Meyer, R. Ray, and R. B. Ray. 1999. Hepatitis C virus NS5A protein modulates the cell cycle regulatory genes and promotes cell growth. J. Gen. Virol. 80:1179-1183.
10. Haddad, J., P. Deny, C. Munz-Gotheil, J. C. Ambrosini, J. C. Trinchet, D. Pateron, F. Mal, P. Callard, and M. Beaugrand. 1992. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323.
11. Hahn, C. S., Y. G. Cho, B. S. Kang, I. M. Lester, and Y. S. Hahn. 2000. The HCV core protein acts as a positive regulator of fas-mediated apoptosis in a human lymphoblastoid T cell line. Virology 276:127-137.
12. Han, J. H., V. Shyamala, K. H. Richman, M. J. Brauer, B. Irivne, M. S. Urdea, P. Tekamp-Olson, G. Kuo, Q. L. Choo, and M. Houghton. 1991. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly (A) tails at the 3′ end. Proc. Natl. Acad. Sci. USA 88:1711-1715.
13. Ikeda, M., M. Yi, K. Li, and S. M. Lemon. 2002. Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76:2997-3006.
14. Ito, T., K. Yasui, J. Mukaigawa, A. Katsume, M. Kohara, and K. Mitamura. 2001. Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system. Hepatology 34:566-572.
15. Lkv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91:2433-2442.
16. Jin, D.-Y., H. L. Wang, Y. Zhou, A. C. Chun, K. V. Kibler, Y. D. Hou, H. Hung, and K. T. Jeang. 2000. Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J. 19:729-740.
17. Kanto, T., N. Hayashi, T. Takehara, H. Hagiwara, E. Mita, M. Naito, A. Kasahara, H. Fusamoto, and T. Kamada. 1994. Buoyant density of hepatitis C virus recovered from infected hosts: two different features in sucrose equilibrium density-gradient centrifugation related to degree of liver inflammation. Hepatology 19:296-302.
18. Kato, N., T. Nakazawa, T. Mizutani, and K. Shimotohno. 1995. Susceptibility of human T-lymphotropic virus type I infected cell line MT-2 to hepatitis C virus infection. Biochem. Biophys. Res. Commun. 206:863-869.
19. Kitay-Cohen, Y., A. Amiel, N. Hilzenrat, D. Buskila, Y. Ashur, M. Fejgin, E. Gaber, R. Safadi, R. Tur-Kaspa, and M. Lishner. 2000. Bcl-2 rearrangement in patients with chronic hepatitis C associated with essential mixed cryoglobulinemia type II. Blood 96:2910-2912.
20. Kuramoto, I. K., T. Moriya, V. Schoening, and P. V. Holland. 2002. Fluctuation of serum HCV-RNA levels in untreated blood donors with chronic hepatitis C virus infection. J. Viral Hepat. 9:36-42.
21. Lanford, R. E., D. Chavez, F. V. Chisari, and C. Sureau. 1995. Lack of detection of negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells and other extrahepatic tissues by the highly strand-specific rTth reverse transcriptase PCR. J. Virol. 69:8079-8083.
22. Laskus, T., M. Radkowski, L. F. Wang, M. Nowicki, and J. Rakela. 2000. Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. J. Virol. 74:1014-1017.
23. Lerat, H., F. Berby, M. A. Trabaud, O. Vidalin, M. Major, C. Trepo, and G. Inchauspe. 1996. Specific detection of hepatitis C virus minus-strand RNA in hematopoietic cells. J. Clin. Investig. 97:845-851.
24. Lin, Y.-J., C. L. Liao, and M. M. C. Lai. 1994. Identification of the cis-acting signal for minus-strand RNA synthesis of a murine coronavirus: implications for the role of minus-strand RNA in RNA replication and transcription. J. Virol. 68:8131-8140.
25. Lohmann, V., F. Korner, J. Koch, U. Herian, L. Theilmann, and R. Bartenschlager. 1999. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 285:110-113.
26. Makino, S., C.-K. Shieh, J. G. Keck, and M. M. C. Lai. 1988. Defectiveinterfering particles of murine coronavirus: mechanism of synthesis of defective viral RNAs. Virology 163:104-111.
27. Mariette, X., M. Zerbib, A. Jaccard, C. Schenmetzler, E. Danon, and J. P. Clauvel. 1993. Hepatitis C virus and Sjögren's syndrome. Arthritis Rheum. 36:280-281.
28. Mellor, J., G. Haydon, C. Blair, W. Livingstone, and P. Simmonds. 1998. Low level or absent in vivo replication of hepatitis C virus and hepatitis G virus/GB virus C in peripheral blood mononuclear cells. J. Gen. Virol. 79:705-714.
29. Moriya, K., H. Fujie, Y. Shintani, H. Yotsuyanagi, T. Tsutsumi, K. Ishibashi, Y. Matsuura, S. Kimura, T. Miyamura, and K. Koike. 1998. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat. Med. 4:1065-1067.
30. Morsica, G., G. Tambussi, G. Sitia, R. Novati, A. Lazzarin, L. Lopalco, and S. Mukenge. 1999. Replication of hepatitis C virus in B lymphocytes (CD19+). Blood 94:1138-1139.
31. Nakajima, N., M. Hijikata, H. Yoshikura, and Y. K. Shimizu. 1996. Characterization of long-term cultures of hepatitis C virus. J. Virol. 70:3325-3329.
32. Nissen, E., M. Hohne, and E. Schreier. 1994. In vitro replication of hepatitis C virus in a human lymphoid cell line (H9). J. Hepatol. 20:437.
33. Pietschmann, T., V. Lohmann, A. Kaul, N. Krigger, G. Rinck, G. Rutter, D. Strand, and R. Bartenschlager. 2002. Persistent and transient replication of full-length hepatitis C virus genomes in cell culture. J. Virol. 76:4008-4021.
34. Radkowski, M., J. Wilkinson, M. Nowicki, D. Adair, H. Vargas, C. Ingui, J. Rakela, and T. Laskus. 2002. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J. Virol. 76:600-608.
35. Ray, R. B., L. M. Lagging, K. Meyer, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:4438-4443.
36. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
37. Selva-O'Callaghan, A., D. Rodriguez-Pardo, L. Sanchez-Sities, L. Matas-Pericas, R. Solans-Laque, J. A. Bosch-Gil, and M. Vilardell-Tarres. 1999. Hepatitis C virus infection, Sjögren's syndrome, and non-Hodgkin's lymphoma. Arthritis Rheum. 42:2489-2490.
38. Shimizu, Y. K., H. Igarashi, T. Kiyohara, M. Shapiro, D. C. Wong, R. H. Purcell, and H. Yoshikura. 1998. Infection of a chimpanzee with hepatitis C virus grown in cell culture. J. Gen. Virol. 79:1383-1386.
39. Shimizu, Y. K., A. Iwamoto, M. Hijikata, R. H. Purcell, and H. Yoshikura. 1992. Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc. Natl. Acad. Sci. USA 89:5477-5481.
40. Shimizu, Y. K., A. J. Weiner, J. Rosenblatt, D. C. Wong, M. Shapiro, T. Popkin, M. Houghton, H. J. Alter, and R. H. Purcell. 1990. Early events in hepatitis C virus infection of chimpanzees. Proc. Natl. Acad. Sci. USA 87:6441-6444.
41. Song, Z. O., F. Hao, F. Min, O. Y. Ma, and G. D. Liu. 2001. Hepatitis C virus infection of human hepatoma cell line 7721 in vitro. World J. Gastroenterol. 7:685-689.
42. Sung, V. M.-H., and M. M. C. Lai. 2002. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system. J. Virol. 76:912-917.
43. Tosato, G. 2000. Generation of Epstein-Barr virus (EBV)-immortalized B cell lines, p. 7.22.1-7.22.3. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., New York, N.Y.
44. Trestard, A., Y. Bacq, L. Buzelay, F. Dubois, F. Barin, A. Goudeau, and P. Roingeard. 1998. Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Arch. Virol. 143:2241-2245.
45. Weiner, A. J., H. M. Geysen, C. Christophersen, J. E. Hall, T. J. Mason, G. Saracco, F. Bonino, K. Crawford, C. D. Marion, K. A. Crawford, M. Brunetto, P. J. Barr, T. Miyamura, J. McHutchinson, and M. Houghton. 1992. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc. Natl. Acad. Sci. USA 89:3468-3472.
46. Zhu, N., A. Khoshnan, R. Schneider, M. Matsumoto, G. Dennert, C. Ware, and M. M. C. Lai. 1998. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J. Virol. 72:3691-3697.
47. Zignego, A. L., and C. Brechot. 1999. Extrahepatic manifestations of HCV infection: facts and controversies, J. Hepatol. 31:369-376.
48. Zignego, A. L., F. Giannelli, M. E. Marrocchi, A. Mazzocca, C. Ferri, C. Giannini, M. Monti, P. Caini, G. L. Villa, G. Laffi, and P. Gentilini. 2000. T(14:18) translocation in chronic hepatitis C virus infection. Hepatology 31:474-479.
49. Zuckerman, E., T. Zuckerman, A. M. Levine, D. Douer, K. Gutekunst, M. Mizokami, D. G. Qian, M. Velankar, B. N. Nathwant, and T. L. Fong. 1997. Hepatitis C virus infection in patients with B cell non-Hodgkin's lymphoma. Ann. Intern. Med. 127:423-428.